වෛද්ය පර්යේෂණ
World's First CRISPR Gene Therapy Approved — A Historic Milestone for Sickle Cell Disease
U.S. regulators approved Casgevy in December 2023 — the world's first medicine based on CRISPR-Cas9 gene editing — offering a potential one-time functional cure for sickle cell disease and marking a watershed moment in the history of genetic medicine.